Results for tag: "End Stage Renal Disease Drug"

End Stage Renal Disease (ESRD) Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. ESRD drugs are used to treat patients with advanced kidney failure, who require dialysis or a kidney transplant. These drugs are used to reduce the symptoms of kidney failure, such as anemia, high blood pressure, and bone disease. They also help to reduce the risk of complications from dialysis and kidney transplantation. Common ESRD drugs include erythropoietin, calcitriol, and iron supplements. The ESRD Drug market is highly competitive, with many companies offering a variety of products. Major players in the market include Amgen, AstraZeneca, Baxter, Fresenius Medical Care, and Novartis. Other companies in the market include AbbVie, Allergan, Daiichi Sankyo, and Merck. Show Less Read more